Cuba studied a total of 2,193 samples for surveillance, 17 of which were positive. The country accumulates 13,943,016 samples taken and 1,105,795 positive.

An innovation developed by Cuban neurosurgeons, which benefits more than 400 children in the central region, was highlighted today on Twitter by the first secretary of the Central Committee of the Cuban Communist Party and president of the country, Miguel Diaz-Canel Bermudez.

Cuban health ministry ( MINSAP by its Spanish acronym)) reported today that 9,970,752 people(90 %) have completed the anti-COVID-19 vaccination program, with the immunogens developed in the country, Soberana 02, Soberana Plus and Abdala.

Cuba studied a total of 2,928 samples for surveillance, 25 were positive. The country accumulates 13,940,823 samples taken and 1,105,778 were positive.

A total of 38,253,410 anti-COVID-19 doses have been administered in Cuba, with the vaccines developed in the country, Soberana 02, Soberana Plus and Abdala.

Cuba is approaching 10 million people with a complete anti-COVID-19 vaccination scheme, reporting today a total of 9,969,774 citizens who have completed the process.

Havana, Jun 16 (ACN) Cuba has administered a total of 37 million 896 thousand 406 doses of its homegrown COVID-19 vaccines Soberana 02, Soberana Plus and Abdala, up to June 14.

A delegation of Cuban experts is in Geneva to attend until Friday three international meetings on chemicals, hazardous wastes and their disposal.

A total of 7,329,613 people in Cuba have anti-COVID-19 booster doses, the Ministry of Public Health (MINSAP) reports today.

Renowned experts in the Health and Biotechnology sectors of Cuba and the Association of Southeast Asian Nations (ASEAN) today held a videoconference to exchange experiences on confronting and containing COVID -19.

A message of recognition and gratitude to blood donors in Cuba, on World Blood Donor Day, Cuban minister of public health, Jose Angel Portal Miranda, sent today.

The Annual Prize of Immunology Jorge Gavilondo Cowley in Memoriam, was awarded to the research work Design, Development and Preclinical Evaluation of Soberana 02: a Cuban vaccine against COVID-19 in the context of the recent Latin American and Caribbean Congress of Immunology (Alaci-2022).

Fulfilling the surgical demand, emergency care and medical assistance of the Maternal and Infant Care Program is possible in Cuba thanks to voluntary blood donations.

Cuba studied a total of 4,173 samples for surveillance, resulting positive 31 for 0.7% of positivity. The country accumulates 13,904,794 samples taken and 1,105,577 positive (8.0%).